The present invention discloses a substituted quinoline compound as shown in formula (I) and a pharmaceutical composition containing the compound, or its polycrystalline form, pharmaceutically acceptable salt, prodrug, stereoisomer, isotopic variant, hydrate or solvent compound, and its use. The quinoline compound and the compound containing the compound can be used as a 5 HT6 receptor antagonist and have better pharmacokinetic parameters and can be used in the preparation of drugs for Alzheimer's disease.
【技术实现步骤摘要】
【国外来华专利技术】PCT国内申请,说明书已公开。
【技术保护点】
PCT国内申请,权利要求书已公开。
【技术特征摘要】
【国外来华专利技术】2016.05....
【专利技术属性】
技术研发人员:王义汉,李焕银,
申请(专利权)人:深圳市塔吉瑞生物医药有限公司,
类型:发明
国别省市:广东,44
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。